-
Mashup Score: 13Genetic factors for ILD—the path of precision medicine - 6 day(s) ago
With increasing awareness of genetic factors and variants involved in the pathogenesis of interstitial lung diseases (ILDs) and expanded availability of genetic testing, pulmonologists diagnosing and managing ILD should appreciate their clinical significance. In patients with a family health history of a similar or the same disease, the term genetic is used to imply one or more underlying genetic components to be causative of the disease with a pathogenic variant. There is a need to use terms precisely and associate pathogenic variants with the specific ILD diagnosis.
Source: www.thelancet.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 0Q&A: Improving ILD diagnosis times through physician education - 2 month(s) ago
Increasing health care worker awareness of interstitial lung diseases can have a major impact on the timing of this diagnosis and receipt of treatment for suffering patients.With this idea in mind, CHEST developed, “‘How We Do It’: CHEST Experts Weigh In.” According to a press release, this project — funded by the Council of Medical Specialty Societies (CMSS) —
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 0Q&A: Improving ILD diagnosis times through physician education - 2 month(s) ago
Increasing health care worker awareness of interstitial lung diseases can have a major impact on the timing of this diagnosis and receipt of treatment for suffering patients.With this idea in mind, CHEST developed, “‘How We Do It’: CHEST Experts Weigh In.” According to a press release, this project — funded by the Council of Medical Specialty Societies (CMSS) —
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 25Interstitial Lung Disease Clinical Practice Guidelines - 7 month(s) ago
Read recommendations for the screening, monitoring, and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic disease.
Source: rheumatology.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0ACR Issues Guideline for Managing ILD in Rheumatic Disease - 7 month(s) ago
“Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD. The full manuscript will be published by early 2024.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Interstitial Lung Disease Clinical Practice Guidelines - 7 month(s) ago
Read recommendations for the screening, monitoring, and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic disease.
Source: rheumatology.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 14Pulmonary Hypertension 2023 - 8 month(s) ago
The field of pulmonary hypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of therapeutic options. The five main groups of pulmonary hypertension differ in epidemiology, causes and risk factors, underlying disease mechanisms, and clinical presentation. Approaches to diagnosis and management reflect the distinctive features of each condition. In the first of a Series of three papers, Marc Humbert and colleagues provide an
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
The field of #pulmonaryhypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of #therapeutic options Find out more in a new @LancetRespirMed Series https://t.co/ALcvKnFvoM #PH #PAH #CTEPH #COPD #ILD https://t.co/9xiHMp5yO4
-
-
Mashup Score: 0Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management - 8 month(s) ago
Patients with chronic lung diseases, particularly interstitial lung disease and chronic obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in clinical deterioration, worsening of oxygen uptake, and an increased mortality risk. Pulmonary hypertension can develop and progress independently from the underlying lung disease. The pulmonary vasculopathy is distinct from that of other forms of pulmonary hypertension, with vascular ablation due to loss of small pulmonary vessels being a key feature.
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Inhaled treprostinil safe, improves outcomes in pulmonary hypertension-ILD over 1 year - 9 month(s) ago
Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.“I hope the impact of this trial and the clear benefit on everyday clinicians is greater awareness so that they look for the disease,” Aaron B. Waxman,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Inhaled treprostinil safe, improves outcomes in pulmonary hypertension-ILD over 1 year - 9 month(s) ago
Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.“I hope the impact of this trial and the clear benefit on everyday clinicians is greater awareness so that they look for the disease,” Aaron B. Waxman,
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
NEW Comment—Genetic factors for #ILD https://t.co/rxNgDoUkR0 "The vision of patients with ILD benefitting from precision medicine and gene-targeted therapeutic interventions is in the immediate future."